Evidence map›Paper›PMID 25972548›Full record

ArticleJournal of virology2015

A Rhesus Rhadinovirus Viral Interferon (IFN) Regulatory Factor Is Virion Associated and Inhibits the Early IFN Antiviral Response.

Gabriela Morin, Bridget A Robinson, Kelsey S Rogers, Scott W Wong

Open access · bronzeAbstract read
In one paragraph

Article in Journal of virology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.7field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 10 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Review
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 4 institutions in 1 country.

Gabriela MorinDepartment of Molecular Microbiology and Immunology, Oregon Health and Science University, Portland, Oregon, USA Vaccine and Gene Therapy Institute, Beaverton, Oregon, USA.
Bridget A RobinsonDepartment of Molecular Microbiology and Immunology, Oregon Health and Science University, Portland, Oregon, USA Vaccine and Gene Therapy Institute, Beaverton, Oregon, USA Department of Global Health, University of Washington, Seattle, Washington, USA.
Kelsey S RogersDepartment of Molecular Microbiology and Immunology, Oregon Health and Science University, Portland, Oregon, USA Vaccine and Gene Therapy Institute, Beaverton, Oregon, USA Department of Human Genetics, University of Utah, Salt Lake City, Utah, USA.
Scott W WongDepartment of Molecular Microbiology and Immunology, Oregon Health and Science University, Portland, Oregon, USA Vaccine and Gene Therapy Institute, Beaverton, Oregon, USA Division of Pathobiology and Immunology, Oregon National Primate Research Center, Beaverton, Oregon, USA wongs@ohsu.edu.
Oregon National Primate Research Center · USUniversity of Utah · USUniversity of Washington · USVaccine and Gene Therapy Institute

Funding

Upgrade of confocal microscopy at the Oregon National Primate Research CenterP51OD011092 · OD · OREGON HEALTH & SCIENCE UNIVERSITY · PI Bonnie J. Nagel · 2012 to 2026
$203.9M
RHESUS HHV 8 HOMOLOGUE IN AIDS RELATED MALIGNANCIESR01CA075922 · NCI · OREGON REGIONAL PRIMATE RESEARCH CENTER · PI WONG, SCOTT W · 1997 to 2024
$16.7M
INTERACTIONS AT THE MICROBE/HOST INTERFACET32AI007472 · NIAID · OREGON HEALTH & SCIENCE UNIVERSITY · PI LANDFEAR, SCOTT M · 1995 to 2019
$6.7M
Program in Molecular and Cellular BiosciencesT32GM071338 · NIGMS · OREGON HEALTH & SCIENCE UNIVERSITY · PI MASLEN, CHERYL L · 2005 to 2020
$3.5M
Training Program in VirologyT32AI074494 · NIAID · OREGON HEALTH & SCIENCE UNIVERSITY · PI NELSON, JAY A · 2009 to 2013
$1.1M
NCI NIH HHS CA075922NCI NIH HHS R01 CA075922NIAID NIH HHS T32 AI007472NIAID NIH HHS T32 AI074494NIAID NIH HHS T32 AI07472NIAID NIH HHS T32 AI74494NIGMS NIH HHS T32 GM071338NIH HHS 8P51OD011092-54NIH HHS P51 OD011092
6 · The paper itself

Abstract

unlabelledThe interferon (IFN) response is the earliest host immune response dedicated to combating viral infection. As such, viruses have evolved strategies to subvert this potent antiviral response. Two closely related gammaherpesviruses, Kaposi's sarcoma-associated herpesvirus (KSHV) and rhesus macaque rhadinovirus (RRV), are unique in that they express viral homologues to cellular interferon regulatory factors (IRFs), termed viral IRFs (vIRFs). Cellular IRFs are a family of transcription factors that are particularly important for the transcription of type I IFNs. Here, we demonstrate a strategy employed by RRV to ensure rapid inhibition of virus-induced type I IFN induction. We found that RRV vIRF R6, when expressed ectopically, interacts with a transcriptional coactivator, CREB-binding protein (CBP), in the nucleus. As a result, phosphorylated IRF3, an important transcriptional regulator in beta interferon (IFN-β) transcription, fails to effectively bind to the IFN-β promoter, thus inhibiting the activation of IFN-β genes. In addition, we found R6 within RRV virion particles via immunoelectron microscopy and, furthermore, that virion-associated R6 is capable of inhibiting the type I IFN response by preventing efficient binding of IRF3/CBP complexes to the IFN-β promoter in the context of infection. The work shown here is the first example of a vIRF being associated with either the KSHV or RRV virion. The presence of this immunomodulatory protein in the RRV virion provides the virus with an immediate mechanism to evade the host IFN response, thus enabling the virus to effectively establish an infection within the host. IMPORTANCE: Kaposi's sarcoma-associated herpesvirus (KSHV) and the closely related rhesus macaque rhadinovirus (RRV) are the only viruses known to encode viral homologues to cellular interferon regulatory factors (IRFs), known as vIRFs. In KSHV, these proteins have been shown to play major roles in a variety of cellular processes and are particularly important in the evasion of the host type I interferon (IFN) response. In this study, we delineate the immunomodulatory mechanism of an RRV vIRF and its ability to assist the virus in rapid immune evasion by being prepackaged within the virion, thus providing evidence, for the first time, of a virion-associated vIRF. This work further contributes to our understanding of the mechanisms behind immunomodulation by the RRV vIRFs during infection.

Indexed as

AnimalsCell LineCREB-Binding ProteinHerpesviridae InfectionsHost-Pathogen InteractionsHumansImmune EvasionInterferon-betaInterferon Regulatory Factor-3Interferon Regulatory FactorsMacaca mulattaPromoter Regions, GeneticProtein BindingRhadinovirusViral ProteinsVirionCREB-Binding ProteinInterferon-betaInterferon Regulatory Factor-3Interferon Regulatory Factorsviral interferon regulatory factorsViral Proteins

Identifiers

PMID25972548
PMCPMC4505633
OpenAlexW2145696151

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.